- CA$424.90m
- CA$764.38m
- CA$5.46m
- 30
- 64
- 42
- 42
2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 66.1 | 239 | 28.1 | 129 | 134 |
Net Total Receivables | 1.29 | 0.481 | 0.741 | 2.62 | 7.24 |
Long Term Investments | |||||
Total Assets | 706 | 576 | 509 | 671 | 813 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 441 | 433 | 242 | 361 | 504 |
Common Stock | |||||
Total Equity | 265 | 143 | 267 | 310 | 309 |
Total Liabilities & Shareholders' Equity | 706 | 576 | 509 | 671 | 813 |
Total Common Shares Outstanding |